课题基金 / 基金详情

Role of ERAD in Epithelial Cell Homeostasis

Role of ERAD in Epithelial Cell Homeostasis
ERAD 在上皮细胞稳态中的作用
批准号:
6889788
负责人:
Timothy Edward Weaver
金额:
$29.01万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-01 至 2009-06-30

项目摘要

项目成果

Timothy Edward Weaver的其他基金

相似基金

相关文献

中文摘要
翻译
表面活性蛋白C(SP-C)仅由肺II型上皮细胞合成, 将蛋白原加工成疏水性成熟肽,以分泌到肺泡腔中。SP-C基因突变最近与家族性和散发性间质性肺病有关。我们的初步研究结果表明,在转基因小鼠的II型上皮细胞中表达疾病相关的SP-C突变导致上皮细胞死亡,并严重扰乱肺形态发生,强烈表明SP-C基因突变可导致肺部疾病。本申请的中心假设是SP-C基因中的突变导致前蛋白的错误折叠和ERAD途径的饱和,导致蛋白质的细胞毒性形式的积累。提出了四个具体目标,以测试 以下假设:(1)不能通过ERAD快速降解突变型proSP-C,导致 前蛋白的细胞毒性形式的积累;(2)新的ERAD蛋白参与突变proSP-C的检测和/或降解;(3)质量控制受体特异性地检测突变proSP-C并分选前蛋白以通过泛素-蛋白酶体途径降解;和(4)体内ERAD的增加将加速突变proSP-C的降解,从而预防/减少突变proSP-C诱导的肺畸形发生。这项工作的长期目标是鉴定选择性增强ERAD的蛋白质,作为与蛋白质错误折叠相关的疾病的潜在治疗靶点。
英文摘要
Surfactant protein C (SP-C) is exclusively synthesized by pulmonary type II epithelial cells which process the proprotein to the hydrophobic mature peptide for secretion into the alveolar airspace. Mutations in the SP-C gene were recently linked to familial and sporadic interstitial lung disease. The results of our preliminary studies indicate that expression of a disease-associated SP-C mutation in type II epithelial cells of transgenic mice leads to epithelial cell death and profoundly perturbed lung morphogenesis strongly suggesting that mutations in the SP-C gene can cause lung disease. The central hypothesis of this application is that mutations in the SP-C gene result in misfolding of the proprotein and saturation of the ERAD pathway leading to accumulation of a cytotoxic form of the protein. Four specific aims are proposed to test the following hypotheses: (1) The inability to rapidly degrade mutant proSP-C via ERAD results in accumulation of a cytotoxic form of the proprotein; (2) Novel ERAD proteins are involved in the detection and/or degradation of mutant proSP-C; (3) A quality control receptor specifically detects mutant proSP-C and sorts the proprotein for degradation via the ubiquitin-proteasome pathway; and (4) Augmentation of ERAD in vivo will accelerate degradation of mutant proSP-C, thereby preventing/reducing mutant proSP-C induced lung dysmorphogenesis. The long term goal of this work is to identify proteins that selectively enhance ERAD for use as potential therapeutic targets in diseases associated with protein misfolding.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Stard7, a Novel Inhibitor of Allergic Lung Disease
  • 批准号:
    8787153
  • 项目类别:
  • 资助金额:
    $38.42万
  • 财政年份:
    2014
  • 负责人:
    Timothy Edward Weaver
  • 依托单位:
Stard7, a Novel Inhibitor of Allergic Lung Disease
  • 批准号:
    8989152
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2014
  • 负责人:
    Timothy Edward Weaver
  • 依托单位:
Stard7, a Novel Inhibitor of Allergic Lung Disease
  • 批准号:
    8656207
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2014
  • 负责人:
    Timothy Edward Weaver
  • 依托单位:
Stard7, a Novel Inhibitor of Allergic Lung Disease
  • 批准号:
    9194427
  • 项目类别:
  • 资助金额:
    $39.0万
  • 财政年份:
    2014
  • 负责人:
    Timothy Edward Weaver
  • 依托单位:
海外基金